Exploring the spectrum of HER2 in non-metastatic triple negative breast cancer: from HER2-Null to HER2-low, including HER2-ultralow status

View at publisher
Authors: Florence Boissière‐Michot, Amélie Gudin-De-Vallerin, Simon Thézenas, Lise Roca, Lopez-Crapez Evelyne, Séverine Guiu, Angélique Bobrie, William Jacot, Aurélie Maran-Gonzalez
Cited by: 1
References: 37

Fields of Study & Subjects

HER2/EGFR in Cancer Research Breast Cancer Treatment Studies Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
Publisher
Springer Science and Business Media LLC
Volume
488
Issue
3
Pages
533–543
Publication date
4 February 2026
Language
EN